NDC product
CAPSULE, LIQUID FILLED · Elysium Pharmaceuticals Ltd
NDC 14803-913 · Elysium Pharmaceuticals Ltd
Key facts
| Product NDC | 14803-913 |
|---|---|
| Nonproprietary name | Acetaminophen 325mg, Guaifenesin 200mg, Dextromethorphan HBr 10mg, Phenylephrine HCl 5 mg |
| Substances | PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN |
| Dosage form | CAPSULE, LIQUID FILLED |
| Labeler | Elysium Pharmaceuticals Ltd |
| Product type | HUMAN OTC DRUG |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Mar 1, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: